文献速递神经儿科影像MR

大环类钆对比剂给药后脑部钆沉积:一项儿科病例对照研究

Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
PubMed 文献 · Radiology · 2017-06-21

该回顾性病例对照研究纳入24例5-18岁脑肿瘤患儿(接受9次以上增强脑MR,2008-2015年)及年龄性别匹配、无GBCA给药的对照,测量齿状核、脑桥、黑质、丘脑枕和苍白球T1信号强度;平均给药14.2次,各ROI信号强度及齿状核/脑桥、苍白球/丘脑枕比值均无显著组间差异,信号变化与给药次数或总剂量无相关性;作者结论为多次静脉给予大环类GBCA在儿童中未导致可测量的T1信号强度增高,需进一步影像与病理研究确认。

要点

  • 儿童多次接受大环类GBCA后,齿状核、脑桥、黑质、丘脑枕、苍白球T1信号强度与无GBCA对照无显著差异。
  • 齿状核/脑桥比值病例组1.0083±0.0373 vs 对照组1.0183±0.01917(P=.37),无显著差异。
  • 信号变化与GBCA给药次数及总剂量均无相关性(各ROI P值均>.05)。

核心结论

  • 儿童多次静脉给予大环类GBCA(钆特醇和钆特酸葡甲胺)后,T1序列信号强度作为脑钆沉积指标未见可测量的增高。

研究设计与样本

  • 回顾性病例对照研究,纳入24例5-18岁脑肿瘤患儿(2008-2015年接受9次以上增强脑MR)及年龄性别匹配、无GBCA给药且神经影像无病理发现的对照。
  • 在未增强T1加权MR图像上测量齿状核、脑桥、黑质、丘脑枕和苍白球5个ROI的信号强度。

关键影像表现/征象

  • 各ROI平均信号强度在病例组与对照组间均无显著差异。
  • 齿状核/脑桥比值病例组1.0083±0.0373 vs 对照组1.0183±0.01917(P=.37),无显著差异。
  • 苍白球/丘脑枕比值病例组1.1335±0.04528 vs 对照组1.1141±0.07058(P=.29),无显著差异。

诊断标准与关键数值

  • 齿状核/脑桥比值:病例组1.0083±0.0373 vs 对照组1.0183±0.01917(P=.37)。
  • 苍白球/丘脑枕比值:病例组1.1335±0.04528 vs 对照组1.1141±0.07058(P=.29)。
  • 信号变化与GBCA给药次数相关性:齿状核r=-0.254(P=.31)、脑桥r=-0.097(P=.65)、黑质r=-0.194(P=.38)、苍白球r=-0.175(P=.41)、丘脑枕r=-0.067(P=.75)。
  • 信号变化与GBCA总剂量相关性:齿状核r=0.091(P=.72)、脑桥r=0.106(P=.62)、黑质r=-0.165(P=.45)、苍白球r=0.111(P=.61)、丘脑枕r=0.173(P=.42)。

临床应用与阅片要点

  • 在儿童增强脑MR随访中,大环类GBCA多次给药后未观察到T1信号强度可测量的增高,可作为评估脑钆沉积的参考依据。
  • 作者结论为需进一步影像与病理研究确认上述发现。

局限性

  • 原文结论指出需进一步影像与病理研究以确认这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine whether signal intensity (SI) in T1 sequences as a potential indicator of gadolinium deposition increases after repeated administration of the macrocyclic gadolinium-based contrast agents (GBCAs) gadoteridol and gadoterate meglumine in a pediatric cohort. Materials and Methods This retrospective case-control study of children with brain tumors who underwent nine or more contrast material-enhanced brain magnetic resonance (MR) imaging studies from 2008 to 2015 was approved by the local ethics board. Informed consent was obtained for MR imaging. Twenty-four case patients aged 5-18 years and appropriate control patients with nonpathologic MR neuroimaging findings (and no GBCA administration), matched for age and sex, were inculded. SI was measured on unenhanced T1-weighted MR images for the following five regions of interest (ROIs): the dentate nucleus (DN), pons, substantia nigra (SN), pulvinar thalami, and globus pallidus (GP). Paired t tests were used to compare SI and SI ratios (DN to pons, GP to thalamus) between case patients and control patients. Pearson correlations between relative signal changes and the number of GBCA administrations and total GBCA dose were calculated. Results The mean number of GBCA administrations was 14.2. No significant differences in mean SI for any ROI and no group differences were found when DN-to-pons and GP-to-pulvinar ratios were compared (DN-to-pons ratio in case patients: mean, 1.0083 ± 0.0373 [standard deviation]; DN-to-pons ratio in control patients: mean, 1.0183 ± 0.01917; P = .37; GP-to-pulvinar ratio in case patients: mean, 1.1335 ± 0.04528; and GP-to-pulvinar ratio in control patients: mean, 1.1141 ± 0.07058; P = .29). No correlation was found between the number of GBCA administrations or the total amount of GBCA administered and signal change for any ROI. (Number of GBCA applications: DN: r = -0.254, P = .31; pons: r = -0.097, P = .65; SN: r = -0.194, P = .38; GP: r = -0.175, P = .41; pulvinar: r = -0.067, P = .75; total amount of administered GBCA: DN: r = 0.091, P = .72; pons: r = 0.106, P = .62; SN: r = -0.165, P = .45; GP: r = 0.111, P = .61; pulvinar: r = 0.173, P = .42.) Conclusion Multiple intravenous administrations of these macrocyclic GBCAs in children were not associated with a measurable increase in SI in T1 sequences as an indicator of brain gadolinium deposition detectable by using MR imaging. Additional imaging and pathologic studies are needed to confirm these findings. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Tibussek D, Rademacher C, Caspers J, et al. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study. Radiology. 2017. PMID: 28640695. doi:10.1148/radiol.2017161151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。